Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit G Pandya

Showing results (91-100 of 142) with videos related to

Pageof 15
Sort By:
Journal of the American Academy of Dermatology|June 10, 2015
Confetti-like depigmentation: A potential sign of rapidly progressing vitiligoJuan Jesús Sosa, Sharif D Currimbhoy, Uzoamaka Ukoha, et al.
Archives of Dermatology|March 21, 2007
Prevalence of self-diagnosed melasma among premenopausal Latino women in Dallas and Fort Worth, TexKelly D Werlinger, Ian L Guevara, Cristina M González, et al.
Journal of the American Academy of Dermatology|October 9, 2017
Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasmaEunice Del Rosario, Stephanie Florez-Pollack, Lucio Zapata, et al.
Journal of the American Academy of Dermatology|April 14, 2021
Transcultural assessment of quality of life in patients with vitiligoAmrita Hans, Keerthi A Reddy, Samantha M Black, et al.
Journal of the American Academy of Dermatology|June 15, 2025
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib in patients with extensive vitiligo in a phase 2, randomized, double-blinded, dose-ranging, placebo-controlled studyAmit G Pandya, Khaled Ezzedine, Thierry Passeron, et al.
Journal of the American Academy of Dermatology|March 23, 2004
A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair lossAnne W Lucky, Daniel J Piacquadio, Cherie M Ditre, et al.
Pediatric Dermatology|July 12, 2016
Acne Knowledge of Hispanic Parents of Teenagers with Mild to Moderate AcneIsha Lopez, Lucio Zapata, Juan Jesús Sosa, et al.
Dermatology and Therapy|March 29, 2025
Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 StudiesJulien Seneschal, Albert Wolkerstorfer, Seemal R Desai, et al.
Journal of Cutaneous Pathology|February 28, 2015
Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous LymphomasTravis Vandergriff, Kaveh A Nezafati, Joseph Susa, et al.
Journal of the American Academy of Dermatology|December 21, 2024
Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension studyYuji Yamaguchi, Elena Peeva, Roni Adiri, et al.
Pageof 15

Showing results (91-100 of 142) with videos related to

Sort By:
Pageof 15
Journal of the American Academy of Dermatology|June 10, 2015
Confetti-like depigmentation: A potential sign of rapidly progressing vitiligoJuan Jesús Sosa, Sharif D Currimbhoy, Uzoamaka Ukoha, et al.
Archives of Dermatology|March 21, 2007
Prevalence of self-diagnosed melasma among premenopausal Latino women in Dallas and Fort Worth, TexKelly D Werlinger, Ian L Guevara, Cristina M González, et al.
Journal of the American Academy of Dermatology|October 9, 2017
Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasmaEunice Del Rosario, Stephanie Florez-Pollack, Lucio Zapata, et al.
Journal of the American Academy of Dermatology|April 14, 2021
Transcultural assessment of quality of life in patients with vitiligoAmrita Hans, Keerthi A Reddy, Samantha M Black, et al.
Journal of the American Academy of Dermatology|June 15, 2025
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib in patients with extensive vitiligo in a phase 2, randomized, double-blinded, dose-ranging, placebo-controlled studyAmit G Pandya, Khaled Ezzedine, Thierry Passeron, et al.
Journal of the American Academy of Dermatology|March 23, 2004
A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair lossAnne W Lucky, Daniel J Piacquadio, Cherie M Ditre, et al.
Pediatric Dermatology|July 12, 2016
Acne Knowledge of Hispanic Parents of Teenagers with Mild to Moderate AcneIsha Lopez, Lucio Zapata, Juan Jesús Sosa, et al.
Dermatology and Therapy|March 29, 2025
Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 StudiesJulien Seneschal, Albert Wolkerstorfer, Seemal R Desai, et al.
Journal of Cutaneous Pathology|February 28, 2015
Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous LymphomasTravis Vandergriff, Kaveh A Nezafati, Joseph Susa, et al.
Journal of the American Academy of Dermatology|December 21, 2024
Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension studyYuji Yamaguchi, Elena Peeva, Roni Adiri, et al.
Pageof 15